Skip to main content
QXL Diagnostics
Cardiology & Heart Verified Clinical Guide

Lipid Profile and Cholesterol Testing: LDL, HDL, Triglycerides, ApoB and Lp(a)

Clinically Reviewed by Dr. Shantakumar Muruda, MD (Medical Biochemistry)Head of Biochemistry · QXL Diagnostics (NABL Lab MC-6849)
November 19, 2026
5 min read
10 Sections
Lipid Profile and Cholesterol Testing: LDL, HDL, Triglycerides, ApoB and Lp(a) - QXL Diagnostics Bengaluru
Share Clinical Guide:
A standard lipid profile evaluates Total Cholesterol, LDL, HDL, and Triglycerides, but advanced cardiovascular risk evaluation increasingly requires Apolipoprotein B (ApoB) and Lipoprotein(a). Learn what your lipid numbers mean and when fasting is required.

💡 AI Direct Answer: What does a lipid profile test measure?#

Direct Clinical Answer: A standard lipid profile measures circulating blood lipids including Total Cholesterol, Low-Density Lipoprotein Cholesterol (LDL-C), High-Density Lipoprotein Cholesterol (HDL-C), and Triglycerides. While these four routine parameters form the foundation of cardiovascular risk evaluation, comprehensive risk assessment in high-risk individuals often incorporates advanced atherogenic markers such as Apolipoprotein B (ApoB) and genetically determined Lipoprotein(a).


Cardiovascular disease (CVD) is the leading cause of mortality in India, frequently striking South Asians a decade earlier than Western populations. A common misconception is that assessing heart risk begins and ends with checking "Total Cholesterol."

In reality, circulating cholesterol is carried in the bloodstream inside specialized spherical macromolecular complexes called lipoproteins. Assessing the atherogenic potential of these lipoproteins requires looking beyond a single total number.


Standard Lipid Profile Components#

A routine laboratory lipid panel quantifies or calculates five primary metrics:

  1. Total Cholesterol (TC): The aggregate cholesterol content across all lipoprotein particles. While a useful baseline, total cholesterol does not distinguish between protective HDL and atherogenic LDL.
  2. Low-Density Lipoprotein Cholesterol (LDL-C): The primary target of lipid-lowering statin therapy. LDL particles enter the arterial sub-endothelial space, undergo oxidative modification, and trigger macrophage foam-cell formation, leading to atherosclerotic plaque.
  3. High-Density Lipoprotein Cholesterol (HDL-C): Mediates reverse cholesterol transport, shuttling excess cholesterol from peripheral arterial tissues back to the liver for biliary excretion.
  4. Triglycerides (TG): Glycerol esterified with three fatty acids, carried primarily in VLDL and chylomicrons. Elevated triglycerides reflect insulin resistance, metabolic syndrome, and excessive refined carbohydrate intake.
  5. Non-HDL Cholesterol: Calculated as Total Cholesterol minus HDL-C. It encompasses all cholesterol carried within atherogenic particles (LDL, VLDL, IDL, Lp(a)).

Standard Lipid Decision Thresholds#

Lipid ParameterDesirable / OptimalBorderline HighHigh Risk Threshold
Total Cholesterol< 200 mg/dL200 – 239 mg/dL≥ 240 mg/dL
LDL Cholesterol< 100 mg/dL (< 70 for high risk)100 – 159 mg/dL≥ 160 mg/dL (≥ 190 very high)
HDL Cholesterol (Men)> 40 mg/dL35 – 39 mg/dL< 40 mg/dL (Major risk factor)
HDL Cholesterol (Women)> 50 mg/dL40 – 49 mg/dL< 50 mg/dL (Major risk factor)
Triglycerides< 150 mg/dL150 – 199 mg/dL≥ 200 mg/dL (≥ 500 pancreatitis risk)
Non-HDL Cholesterol< 130 mg/dL130 – 159 mg/dL≥ 160 mg/dL

Do Lipid Profiles Always Require Fasting?#

No.

Guidelines from the European Society of Cardiology (ESC) and American College of Cardiology (ACC) confirm that non-fasting blood draws are fully acceptable for routine initial cardiovascular screening. Post-prandial total cholesterol, HDL-C, and LDL-C differ by less than 2–5% from fasting levels.

However, an overnight fast of 10 to 12 hours is still recommended when:

  • Triglyceride levels on a non-fasting test exceed 400 mg/dL;
  • Assessing patients with known severe hypertriglyceridemia or genetic dyslipidemia;
  • Investigating pancreatitis risk;
  • Explicitly requested by your treating cardiologist.

Beyond Routine Lipids: What is ApoB?#

Every atherogenic lipoprotein particle—including LDL, VLDL, IDL, and Lp(a)—carries exactly one molecule of Apolipoprotein B-100 (ApoB) on its surface.

In contrast, the amount of cholesterol carried within each LDL particle varies substantially. In individuals with insulin resistance, type 2 diabetes, or abdominal obesity, LDL particles are often small and dense, meaning cholesterol concentration (LDL-C) appears deceptively normal while the actual particle count (ApoB) is dangerously elevated.

Measuring ApoB directly quantifies the total number of circulating plaque-forming particles, resolving discordance and offering superior risk prediction.


What is Lipoprotein(a) — Lp(a)?#

Lipoprotein(a), or Lp(a), is an LDL particle covalently linked to a unique glycoprotein called apolipoprotein(a). Circulating Lp(a) levels are > 90% genetically predetermined by variations in the LPA gene and remain remarkably stable throughout adult life, unaffected by diet, exercise, or routine statin therapy.

Elevated Lp(a) (> 50 mg/dL or > 125 nmol/L) promotes both atherosclerosis and thrombosis. South Asians carry a disproportionate burden of elevated Lp(a). International guidelines now recommend that every adult undergo Lp(a) testing at least once in their lifetime to uncover hidden inherited cardiovascular risk.



Frequently Asked Questions#

Can exercise raise good HDL cholesterol?#

Yes. Regular aerobic exercise, smoking cessation, and replacing refined carbohydrates with healthy monounsaturated fats can modestly increase HDL levels.

Does a low total cholesterol guarantee clean arteries?#

No. Atherosclerosis is driven by inflammation, smoking, vascular shear stress, and particle number (ApoB). Up to 50% of heart attack patients present with 'normal' total cholesterol.


Clinical References & Guidelines#

  1. Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation; 2019.
  2. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal; 2020.
  3. Kronenberg F, et al. Lipoprotein(a) in atherosclerosis and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J; 2022.
  4. American Diabetes Association. Standards of Care in Diabetes — Cardiovascular Disease and Risk Management. Diabetes Care; 2024.

Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.

Medical & Laboratory Disclaimer

Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.

Medically Reviewed & Fact-Checked Reviewed: November 19, 2026

Dr. Shantakumar Muruda, MD (Medical Biochemistry)

Head of Clinical Biochemistry & Quality Management, QXL Diagnostics Bengaluru (NABL Accredited Laboratory MC-6849). Trained Lead Assessor for ISO 15189:2022 medical laboratory standards.

QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

Share Clinical Guide:

Related Clinical Guides

Explore more evidence-based diagnostic articles and testing guidelines